News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neuro-Hitech Announces Agreement To Acquire Q-RNA


11/17/2006 10:21:02 AM

NEW YORK, NY--(MARKET WIRE)--Nov 17, 2006 -- Neuro-Hitech, Inc. (OTC BB:NHPI.OB - News), a biopharmaceutical company focused on the development and commercialization of next-generation compounds against proven targets for neurodegenerative diseases, announced today that it has entered into a definitive merger agreement to acquire Q-RNA, Inc., a New York-based biotechnology company focused on diseases such as Alzheimer's, epilepsy, and Parkinson's disease. The completion of the merger is subject to customary closing conditions, including the accuracy of the representations and warranties, the absence of any materially adverse change in the business or financial condition of Q-RNA, approval by Q-RNA security holders and an investment of an aggregate of at least $3.1 million in Neuro-Hitech by private equity firms and their affiliates, including the principal Q-RNA security holders.

>>> Discuss This Story


Read at Market Wired


comments powered by Disqus
Q-RNA
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES